Blood serum neopterin, high sensitivity C-reactive protein (hsCRP), total homocysteine, pyridoxal-5-phosphatc ( P-5-P) and total phospholipid concentrations have been examined in 30 healthy individuals as well as in patients with coronary artery disease (CAD) verified by coronary angiography (43 patients with 1-artery disease, 24 patients with 2-or 3-artery disease, 17 patients with restenosis) before percutaneous transluminal coronary angioplasty. We have observed increased mean concentrations of neopterin, hsCRP and homocysteine as well as decreased mean concentration of P-5-P and phospholipids in all groups of CAD patients. The positive correlation between neopterin and hsCRP in all CAD patients (r = 0.536; Ρ <0.01 ) as well as an increased frequency of these indices above the upper limit of normal during the course of CAD (30.1 % in eases with 1-artery disease, 54.2% of cases in 2-or 3-artery disease, 76.5% of cases in restenosis) allow to conclude that inflammation has a pivotal role in the progression of CAD. In restenosis the determination ot neopterin was of more significance than the determination of hsCRP. The combination of a mild increase of neopterin and homocysteine concentrations points to the worst prognosis of CAD, both after percutaneous transluminal coronary angioplasty and coronary bypass, restenosis was most liekly to appear. Mild increase of homocysteine concentration in patients with CAD docts not only indicate possible thickening of arterial wall and narrowing of lumen but also to impaired trans-sulfuration and remethylation pathways of homocysteine metabolism as well as to delayed methylation processes in the organism. A decrease of serum P-5-P concentration, which in all groups of CAD patiens reached about 50% as compared with healthy individuals, points to impairment of all metabolic processes, which require the biologically active form of vitamin B6 for their action. The decrease of mean serum phospholipid concentration in all groups of CAD patients may indicate both, impaired phospholipid biosynthesis due to delayed processes of methylation in the organism and increased loss of phosphatidylcholine necessary for transportation of oxidised low density lipoproteins into macrophages. Therefore the determination of serum phospholipid concentration and phosphatidylcholine concentration, especially, has the same significance in the course of CAD as the determination of total cholesterol, high and low density lipoprotein cholesterol widely used at present.
Introduction
Atherosclerosis in general as well as atherosclerosis of coronary arteries resembles chronic inflammation in several regards, and it is now recognised that cellular components of the immune system are involved in their genesis (1) . Endothelial function is critical to maintain blood flow and vascular integrity. So healthy endothelium tends to favour vasodilatation, antithrombosis. fibrinolysis and monocyte disadhesion. Endothelial cells present the only surface that, during protracted contact, can maintain blood in a liquid state. Acutc and especially chronic minimal endothelial injury can result in dysfunctional endothelium characterised by increased uptake of low density lipoprotein (LDL) and monocyte recruitment into the blood vessel Rudzite V. et al.· . Neopterin, CRP, Homocysteine, Pyridoxal-5-phosphatc, Phospholipid in CAD wall, which are both pivotal in the initiation of atherosclerosis (2) . Neopterin is a product of interferon-γ-activated monocyte-derived macrophages and is a sensitive marker for Thl-type immune response (3) . C-reactive protein (CRP) is rapidly secreted by the liver in response to trauma, inflammation and infection and decreases immediately after resolution of the conditions (4) . Despite of many well characterised antiinflammatory and phagocytosis-mediated reactions of CRP (5) (6) (7) (8) , results of further investigation showed that CRP could activate blood monocytes and stimulate the production of inflammatory cytokines: interleukin (1L)-1 and tumor necrosis factor-α (TNF-a) in human monocytes (9) . These monocytes migrate to the place of inflammation, infection or traumatic injury and there, localized in the intima of the vessel wall, transform into macrophages within 7-8 days (10). Macrophages not only produce IL-1 and TNF-a, but also interferon-γ (11). TNF-a together with interferon-γ activates GTP cyclohydrolase I that cleaves guanosine triphosphate (GTP) to 7,8-dihydroneopterin triphosphate in macrophages. From this key metabolite of pterin biosynthesis both, 7,8-dihydroneopterin and 5,6,7,8-tetrahydrobiopterin (H4Bip), can be formed. Due to low activity of enzyme 6-pyruvoyl-tetrahydropterin synthase in macrophages, 7,8-dihydroneopterin is formed by phosphatases. It is metabolised to neopterin, which may be found in biological fluids of such patients (12) . H4Bip is a cofactor necessary for the activation of nitric oxide (NO) synthases that cleave L-arginine and form NO (= endothcliumderived-relaxing-factor, EDRF) (13, 14) . Contrary to macrophages, human vascular endothelial cells express all enzymes for de novo II4Bip biosynthesis. The bioavailability of H4Bip is pivotal for endothelial function, and intracellular H4Bip levels potentially regulate endothelial NO synthesis and vascular tone (15) (16) (17) . Inhibition of H4Bip synthesis is followed by a reduction of endothelial NO production (18) . Since in cultivated human smooth muscle cells, neither inducible NO synthase nor endothelial NO synthase mRNA is delected in the resting state ( 19.20) it can be assumed that H4Bip should not induce any direct NOmediated relaxing effect on smooth muscle cells under physiological conditions. It is suggested that H4Bip produced endogenously in endothelial cells or elsewhere in the human body, traffics into smooth muscle cells of the body vessels, and relaxation is followed by dose dependent increases of intracellular cGMP levels (21) . In inflammatory conditions after increased NO synthesis in endothelial cells of human blood vessels the concomitant dramatic decrease of endothelial NO synthase mRNA makes this increase only transient and significantly reduced NO production is expected to occur after certain time of ongoing inflammation in a man (22) . The level of intracellular H4Bip is critical for the degree of reactive oxygen intermediates production by endothelial NO synthase: such as superoxide anions, hydrogen peroxide and hydroxyl radicals. It in turn can interact with the vascular signalling systems and potentially oxidizes any molecule in a cell, causing DNA nicking and disruption, lipid peroxidation, and protein cross-linking and degradation (23) (24) (25) .
After the observation that homocysteine promotes vascular endothelial (26) and smooth muscle cell (27) growth, this amino acid has been proposed to be linked with atherosclerosis development and progression. In mammals homocysteine is formed from the essential amino acid methionine. Methionine adenosine transferase in the presence of ATP forms S-adenosylmethionine that is the principal biological methyl group donor (28) . Methyl groups are required for numerous methylation reactions, of which about 100 have been identified. Among them are phospholipids (29) , which contribute to keep blood cholesterol in solution and so prevent atherosclerosis development and progression. After giving methyl-groups, S-adenosylmethionine transforms into S-adenosylhomocysteine and then further into homocysteine. Homocysteine can be cleaved to cysteine by P-5-P dependent enzyme systems (30) and/or remethylated to methionine by betaine-homocysteine methyltransferase in liver cells and by 5,10-methylenetetrahydrofolate reductase and methionine synthase in cells of other tissues (29) . S-adenosylhomocysteine is a potent competitor to S-adenosylmethionine at different binding sites and can therefore inhibit methylation (31) . Moreover, an elevation of total homocysteine (homocysteine + S-adenosyl-homocysteine) could probably also serve as an index for delayed methylation and so impaired different pathways of intercellular metabolism. Therefore the aim of this study was to examine the changes of neopterin, CRP, homocysteine, P-5-P and phospholipid concentrations in CAD patients and to evaluate these changes in the progression of CAD.
Material and Methods
Thirty Healthy individuals and 84 patients with CAD verified by coronary angiography were examined in this study before percutaneous transluminal coronary angioplasty. Patients with Diabetes and/or renal complications as well as patients who received statins in their treatment were excluded. In total, 43 patients with 1-artery disease, 24 patients with 2-or 3-artery disease and 17 patients with restenosis were been included. Blood serum concentrations of neopterin (BRAHMS, Berlin Germany), hsCRP (Dade Behring) and homocysteine (Abbot IMx) were measured by commercially available immunoassay according to manufacturer's instructions. The method of Serfontein and others (32) was used for the determination of P-5-P in blood serum. After extraction of lipids from blood serum by the method of Folch and others (33) , the method of Urbach and Raabe (34) was used to determine phospholipid concentrations. Mean values, standard deviations (S.D.) and standard error (S.E.) of means were calculated. Statistical significance between the values obtained from healthy individuals (control) and the groups of CAD patients as well as between the values obtained from patients with 1-artery disease and patients with restenosis were calculated by Student's t-test. Ρ values <0.05 were considered to indicate significant differences. Linear correlation coefficients were calculated. was observed in all groups of CAD patients, but statistical significance of elevation was found only in patients with 2-or 3-artery disease (P <0.05) as well as in patients with restenosis (P <0.001). Patients with restenosis had significantly higher CRP concentrations when compared with patients with 1-artery disease (P <0.01). There existed a positive correlation between neopterin and hsCRP concentrations in all observed CAD patients (r = 0.536; Ρ <0.01). An elevation of neopterin and hsCRP concentrations above the upper limit of the normal was found in 30.1% of cases with 1-artery disease, in 54.2% of cases with 2-or 3-artery disease and in 76.5 % of cases with restenosis (Table 1 ) . In patients with restenosis the elevation of neopterin concentration above the upper limit of the normal was found more frequently than the elevation of hsCRP. From the data of Abbot IMx manufacturer's the con- with restenosis compared with patients with 1-artery disease (P <0.001). The correlation (r = -0.321) between phospholipid and homocysteine concentrations was inverse (not significant).
Results

Discussion
The initial lesion of atherosclerosis develops when monocytes cross the endothelial barrier to accumulate in the intima (39) . The traffic of monocytes probably is induced by CRP (4). Monocytes loeated in the intima are transformed into macrophages within 7-8 days (10). CRP is also able to induce inflammatory cytokines IL-1 and TNF-a in human monocytes (9) and macrophages ( ! 1 ). These cytokines together with interferon-γ stimulate an increase of 7,8 dihydroneopterin and neopterin formation in macrophages due to low activity of 6-pyruvoyl-tetrahydropterin synthase necessary for I14Bip biosynthesis (12) . This study shows increased neopterin and hsCRP concentrations (Fig. 1, Fig. 2 ) in all groups of CAD patients as well as positive correlation between these markers of immune activation and inflammation (r = 0.536). Moreover, the increase of serum neopterin and hsCRP concentrations above the upper limit of the normal range was found more frequently in patients with 2-or 3-artery disease and, especially, in patients with restenosis as compared with patients with 1-artery disease (Table 1) . So our data points to the role of inflammation in the progression of CAD.
Elevated neopterin concentration predicts adverse events in patients with non Q-wave myocardial infarction. When increased CRP levels are added, the predictive value becomes even stronger (40) . Our observation about more frequent increase of neopterin concentration than CRP protein elevation in patients with restenosis (see Table 1 ) further extends these data of literature.
Homocysteine stimulates the growth of endothelial and smooth muscle cells in vitro (26, 27) . So mild elevation of serum homocysteine concentration in all groups of CAD (Fig. 3) may reflect a possible thickening of blood-vessels wall and narrowing of lumen. The pathobiology of restenosis after PTCA is characteristic and distinct from that of de novo atherosclerosis. As reviewed by Libby (2), loss of luminal calibcr alter balloon angioplasty may induce vessel constriction from the adventitial side (negative remodeling), which has renewed an adventitial inflammation with scar formation, wound contraction and so restenosis. In contrast. in-stent stenosis depends on intimai thickening. In, general it would appear that plasma lipid concentrations are not related to risk for restenosis (41) (42) (43) . Moreover, all clinical trials have shown that statin therapy does not prevent restenosis (44) . Mild increase of serum homocysteine concentration in restenosis patients of this study and in our previous investigations (45) as well as positive correlation between neopterin and homocysteine concentrations in patients with restenosis of this study (r = 0.485) and in CAD patients of our previous investigations (46) show the need of further investigations to answer this question. Profoundly decreased P-5-P serum concentrations in this study (Fig. 4) as well as in our previous investigations (45, 47) show a possible pathogenetic role in the development of increased homocysteine concentration observed in patients with CAD.
The decrease of phospholipid serum concentrations in all groups of ( ΑΠ patients (Fig. 5) , especially, in patients with restenosis, indicates possibly delayed methylation processes in organism due to slight increase of serum homocysteine (homocysteine + Sadenosylhomocysteine) (29, 36) in these patients. The decrease of serum phospholipid concentrations may also be due to increased levels of CRP in CAD patients, because CRP interacts with phosphatidylcholine and so prepares lipids for phagocytosis. Recently it was found that LDL cholesterol, which plays a pivotal role in atherogenesis, contains negatively charged phospholipids. Binding of CRP to these phospholipids increases uptake of oxidised LDL by macrophages providing a basis for atherogenesis (48 ) . Therefore, the determination of phospholipid concentrations, especially phosphatidylcholine serum concentrations, in the course of CAD may have the same significance as the determination of total cholesterol, HDL-cholesterol and LDL-cholesterol widely used at present.
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